The importance of gold standard partnerships in conducting large scale cancer screening studies

The era of precision oncology is empowering the biopharmaceutical industry to deliver breakthrough therapeutics for patients with cancer. In this webinar, Mike Sheldon, Director of Scientific Affairs at Sampled and Erika Vento-Gaudens, Director of Global Clinical Studies Operations at Guardant will describe the partnership established between Guardant Health and Sampled to build a study workflow that spans from subject enrollment through sample collection, processing, distribution, and analysis. Partnerships such as these bring companies with complementary resources and skills together to help transform how cancer is detected, treated, and managed.

Guardant Health is dedicated to helping patients at all stages of cancer live longer and healthier lives through the power of blood tests and the data they unlock. From informing better treatment in patients with advanced cancer, to new ways of monitoring recurrence in cancer survivors, and screening to find cancer at its earliest and most treatable in the general population.

This webinar will consider the example of ECLIPSE, a prospective, multi-site registrational study to evaluate the performance of Guardant’s LUNAR-2 blood test to detect colorectal cancer. This important study relies on the data collected from a large cohort of tens of thousands of subjects from a variety of age and ethnic groups.

The success of a study like ECLIPSE depends critically on the ability to collect, process, and analyze biospecimens from a large number of subjects in a timely manner with utmost care to the safeguarding of the integrity and quality of all data and samples that are part of the study. In this webinar explore how this ambitious study was carried out to drive precision health innovation and transform patient healthcare.

Key learning objectives

Understand the key elements to successful partnerships in large scale studies.
Background of the ECLIPSE clinical trial which is a large-scale colorectal cancer screening study, one of the largest of its kind.
Understand the importance of collaboration with service partners to deliver gold standard service.

Who should attend?